Hypernal drops: an effective drug for the treatment of arterial hypertension and other diseases
Hypernal drops are a drug from the group of calcium channel blockers of the dihydropyridine group, which is produced by Berlin-Chemie AG in Germany. The active substance of the drug, nifedipine, is widely used for the treatment of arterial hypertension, hypertrophic cardiomyopathy, Raynaud's disease, pulmonary hypertension, broncho-obstructive syndrome and the prevention of angina attacks, including Prinzmetal's angina.
The drug is available in the dosage form of an oral solution with a concentration of 20 mg/ml. Hypernal drops are produced in various dosages, including Hypernal 10, Hypernal 5, Calcigard, Calcigard retard, Calcigard-10, Calcigard-5, Cordipin, Cordipin XL, Cordipin HL and Cordipin-reta.
The drug has several contraindications, including hypersensitivity to nifedipine, acute myocardial infarction, cardiogenic shock, severe aortic stenosis, decompensated heart failure, severe arterial hypotension, tachycardia, pregnancy and breastfeeding. The drug is also not recommended for use in pediatric practice, since the safety and effectiveness of its use in children have not been determined.
When using Hypernal drops, side effects may occur, which include dizziness, headache, stupor, changes in visual perception, impaired sensitivity in the arms and legs, constipation, nausea, diarrhea, gum hyperplasia (with long-term treatment), increased activity of liver transaminases, bronchospasm , myalgia, tremor, allergic reactions, swelling and redness of the hands and feet, photodermatitis, hyperglycemia, gynecomastia (in elderly patients), burning sensation at the injection site (with intravenous administration), facial flushing with a feeling of heat, palpitations, tachycardia, hypotension (up to fainting), pain similar to angina pectoris, very rarely - anemia, leukopenia, thrombocytopenia, thrombocytopenic purpura.
Hypernal drops may interact with nitrates, diuretics, beta-blockers, protein kinase inhibitors, anticoagulants, antidepressants, antibiotics, aminoglycosides, antiepileptic drugs and anesthetics. Therefore, before starting treatment with Hypernal drops, you must consult your doctor to avoid possible unwanted interactions with other drugs.
The dosage and regimen of taking Hypernal drops are determined by the doctor individually depending on the severity of the disease, age and condition of the patient. It is usually recommended to start treatment with low doses and gradually increase them until the optimal therapeutic effect is achieved. The drug is taken orally with a sufficient amount of water. The solution must be shaken thoroughly before use.
In general, Hypernal drops are an effective and safe drug for the treatment of arterial hypertension and other diseases, but require prescription and monitoring by a doctor. Patients should follow the doctor's recommendations regarding the dosage and regimen of taking the drug, as well as monitor possible side effects and immediately report them to the doctor.